Author:
Saruwatari Junji,Yasui-Furukori Norio,Inoue Yoshimasa,Kaneko Sunao
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference14 articles.
1. Heading CE (1998) AD-5423 (Dainippon Pharmaceutical Co Ltd). IDrugs 1(7):813–817
2. Dainippon Sumitomo Pharma Co., Ltd (2009) Lonasen® (blonanserin). Interview form (in Japanese). http://ds-pharma.jp/medical/product/dbps_data/_material_/product/lonasen/lonasen_tabpow_interv.pdf Accessed 8 March 2010
3. Garcia E, Robert M et al (2009) The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study. CNS Drugs 23(7):615–625
4. Kumagai R, Ichimiya Y (2009) Efficacy of blonanserin in combination therapy for treatment-resistant depression. Psychiatry Clin Neurosci 63(4):593–594
5. Jordan S, Knight J et al (2004) Monitoring adverse drug reactions: scales, profiles, and checklists. Int Nurs Rev 51(4):208–221
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献